Blog

FOR IMMEDIATE RELEASE Credit: Valsamo “Elsa” Anagnostou using DALL-E FOR IMMEDIATE RELEASE Using a “liquid biopsy” to study genetic material from tumors shed into the bloodstream together with immune cells could help clinicians predict which patients with advanced lung cancers are responding to immunotherapies and

Interstitial fluid flow is closely related to drug delivery and distribution, playing a crucial role in their therapeutic effects on tumours. However, few non-invasive measurement methods are available for measuring low-velocity biological fluid flow. Credit: Jun Zhao, Yupeng Cao, Wentao Liu, Dong Han Interstitial fluid

Researchers have come one step closer to answering why, in some patients, a type of lymphoma changes from indolent to aggressive, and in particular they are closer to identifying which patients are at high risk of this change happening. Credit: Photo: Simon Byrial Fischel/Aarhus University

This review is designed and written by Dr. Yu Zheng and her graduate student Qin Qin (Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University). Credit: Not applicable This review is designed and written by Dr. Yu Zheng and her graduate student Qin Qin (Department of Biotherapy, Cancer Center and State

DOWNLOADABLE VIDEO IS AVAILABLE HERE Credit: Photo by Clutch Content Partners DOWNLOADABLE VIDEO IS AVAILABLE HERE MIAMI, FLORIDA (EMBARGOED UNTIL MONDAY, DEC. 11, 2023, AT 8:45 PM ET) – CAR-T cell therapy is a safe and effective treatment for diffuse large B-cell lymphoma (DLBCL), even

DOWNOADABLE VIDEO Credit: Photo by Clutch Content Partners DOWNOADABLE VIDEO MIAMI, FLORIDA (EMBARGOED UNTIL MONDAY, DEC. 11, 2023 AT 8:45 P.M. ET) – Researchers conducting a Phase 2 clinical trial at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine say

DOWNLOADABLE VIDEO Credit: Photo by Clutch Content Partners DOWNLOADABLE VIDEO MIAMI, FLORIDA (EMBARGOED UNTIL MONDAY, DEC. 11, 2023 @ 7 P.M. ET) – In a study led by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, patients recently

The Malaghan Institute of Medical Research in collaboration with Wellington Zhaotai Therapies Limited today announced results of its phase 1 dose escalation trial of a new third generation anti-CD19 chimeric antigen receptor (CAR) T-cell therapy to be presented at the American Society of Hematology (ASH)

“This review revealed 29 primary risk factors associated with arm morbidity after breast cancer treatment.” Credit: 2023 Klein et al. “This review revealed 29 primary risk factors associated with arm morbidity after breast cancer treatment.” BUFFALO, NY- December 11, 2023 – A new review paper

PLYMOUTH MEETING, PA [December 11, 2023] — New research in the December 2023 issue of JNCCN—Journal of the National Comprehensive Cancer Network finds patients treated with first-line immunotherapy for advanced Non-Small Cell Lung Cancer (NSCLC) showed similar results in terms of survival, progression-free survival, and